iSpecimen (ISPC) Total Current Liabilities (2020 - 2026)

iSpecimen's Total Current Liabilities history runs 7 years deep, the most recent figure standing at $5.6 million for Q1 2026.

• In Q1 2026, Total Current Liabilities rose 13.82% year-over-year to $5.6 million; the TTM figure through Mar 2026 stood at $5.6 million (up 13.82% YoY), while the FY2025 annual figure was $6.2 million, up 7.99% from the prior year.
• Total Current Liabilities for Q1 2026 stood at $5.6 million, down from $6.2 million in the prior quarter.
• The five-year high for Total Current Liabilities was $6.3 million in Q3 2024, with the low at $2.0 million in Q2 2022.
• The 5-year median for Total Current Liabilities is $5.2 million (2025), against an average of $4.6 million.
• The sharpest annual moves came in 2022 and 2024: Total Current Liabilities plunged 65.75% in 2022, then soared 103.25% in 2024.
• iSpecimen's Total Current Liabilities stood at $4.3 million in 2022, then jumped by 41.29% to $6.0 million in 2023, then declined by 4.6% to $5.8 million in 2024, then increased by 7.99% to $6.2 million in 2025, then dropped by 10.14% to $5.6 million in 2026.
• Business Quant data shows ISPC's Total Current Liabilities at $5.6 million in Q1 2026, $6.2 million in Q4 2025, and $5.7 million in Q3 2025.